Prosecution Insights
Last updated: April 19, 2026

Drugcendr Australia Pty Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
16812107 LOW-DOSE CYTOKINE CO-ADMINISTERED WITH IRGD FOR TREATING CANCER SABILA, MERCY HELLEN 1654 Final Rejection Mar 06, 2020

Managing Drugcendr Australia Pty Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month